{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04856085",
            "orgStudyIdInfo": {
                "id": "VIR-2218-1006"
            },
            "organization": {
                "fullName": "Vir Biotechnology, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of VIR-2218, VIR-3434, and/or PEG-IFN\u03b1 in Subjects With Chronic Hepatitis B Virus Infection",
            "officialTitle": "A Phase 2 Study to Evaluate the Safety, Tolerability, and Efficacy of Regimens Containing VIR-2218, VIR-3434, and/or PEG-IFN\u03b1 in Subjects With Chronic Hepatitis B Virus Infection",
            "acronym": "MARCH",
            "therapeuticArea": [
                "Gastroenterology"
            ],
            "study": "study-of-vir-vir-and-or-peg-in-subjects-with-chronic-hepatitis-b-virus-infection"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-09",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-07-11",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-04-21",
            "studyFirstSubmitQcDate": "2021-04-21",
            "studyFirstPostDateStruct": {
                "date": "2021-04-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Vir Biotechnology, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "This is a phase 2 study in which participants with chronic hepatitis B virus (HBV) infection will receive VIR-2218, VIR-3434 and/or PEG-IFN\u03b1 and be assessed for safety, tolerability, and efficacy"
        },
        "conditionsModule": {
            "conditions": [
                "Hepatitis B, Chronic"
            ],
            "keywords": [
                "Hepatitis B Virus",
                "Chronic Hepatitis B",
                "HBV",
                "Hepatitis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 415,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort 1a (VIR-2218 + VIR-3434)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive multiple lead-in doses of VIR-2218, then combination therapy with VIR-2218 + VIR-3434 for 20 weeks total",
                    "interventionNames": [
                        "Drug: VIR-2218",
                        "Drug: VIR-3434"
                    ]
                },
                {
                    "label": "Cohort 2a (VIR-2218 + VIR-3434)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive multiple lead-in doses of VIR-2218, then combination therapy with VIR-2218 + VIR-3434 for 20 weeks total",
                    "interventionNames": [
                        "Drug: VIR-2218",
                        "Drug: VIR-3434"
                    ]
                },
                {
                    "label": "Cohort 3a (VIR-2218 + VIR-3434)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive multiple doses of VIR-2218 + VIR-3434 for 4 weeks",
                    "interventionNames": [
                        "Drug: VIR-2218",
                        "Drug: VIR-3434"
                    ]
                },
                {
                    "label": "Cohort 4a (VIR-2218 + VIR-3434)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive multiple doses of VIR-2218 + VIR-3434 for 4 weeks",
                    "interventionNames": [
                        "Drug: VIR-2218",
                        "Drug: VIR-3434"
                    ]
                },
                {
                    "label": "Cohort 5a (VIR-2218 + VIR-3434)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive multiple doses of VIR-2218 + VIR-3434 for 11 weeks",
                    "interventionNames": [
                        "Drug: VIR-2218",
                        "Drug: VIR-3434"
                    ]
                },
                {
                    "label": "Cohort 6a (VIR-2218 + VIR-3434)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive multiple doses of VIR-2218 + VIR-3434 for 11 weeks",
                    "interventionNames": [
                        "Drug: VIR-2218",
                        "Drug: VIR-3434"
                    ]
                },
                {
                    "label": "Cohort 7a (VIR-2218 + VIR-3434)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive multiple doses of VIR-2218 + VIR-3434 for 44 weeks",
                    "interventionNames": [
                        "Drug: VIR-2218",
                        "Drug: VIR-3434"
                    ]
                },
                {
                    "label": "Cohort 8a (VIR-2218 + VIR-3434)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive multiple doses of VIR-2218 + VIR-3434 for 20 weeks",
                    "interventionNames": [
                        "Drug: VIR-2218",
                        "Drug: VIR-3434"
                    ]
                },
                {
                    "label": "Cohort 1b (VIR-3434)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive multiple doses of VIR-3434 for 44 weeks",
                    "interventionNames": [
                        "Drug: VIR-3434"
                    ]
                },
                {
                    "label": "Cohort 2b (VIR-3434)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive multiple doses of VIR-3434 for 20 weeks",
                    "interventionNames": [
                        "Drug: VIR-3434"
                    ]
                },
                {
                    "label": "Cohort 1c (VIR-2218 + VIR-3434 + PEG-IFN\u03b1)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive multiple doses of VIR-2218 + VIR-3434 + PEG-IFN\u03b1 for 24 weeks",
                    "interventionNames": [
                        "Drug: VIR-2218",
                        "Drug: VIR-3434",
                        "Drug: PEG-IFN\u03b1"
                    ]
                },
                {
                    "label": "Cohort 2c (VIR-2218 + VIR-3434 + PEG-IFN\u03b1)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive multiple doses of VIR-2218 + VIR-3434 + PEG-IFN\u03b1 for 48 weeks",
                    "interventionNames": [
                        "Drug: VIR-2218",
                        "Drug: VIR-3434",
                        "Drug: PEG-IFN\u03b1"
                    ]
                },
                {
                    "label": "Cohort 1d (VIR-3434 + PEG-IFN\u03b1)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive multiple doses of VIR-3434 + PEG-IFN\u03b1 for 48 weeks",
                    "interventionNames": [
                        "Drug: VIR-3434",
                        "Drug: PEG-IFN\u03b1"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "VIR-2218",
                    "description": "VIR-2218 given by subcutaneous injection",
                    "armGroupLabels": [
                        "Cohort 1a (VIR-2218 + VIR-3434)",
                        "Cohort 1c (VIR-2218 + VIR-3434 + PEG-IFN\u03b1)",
                        "Cohort 2a (VIR-2218 + VIR-3434)",
                        "Cohort 2c (VIR-2218 + VIR-3434 + PEG-IFN\u03b1)",
                        "Cohort 3a (VIR-2218 + VIR-3434)",
                        "Cohort 4a (VIR-2218 + VIR-3434)",
                        "Cohort 5a (VIR-2218 + VIR-3434)",
                        "Cohort 6a (VIR-2218 + VIR-3434)",
                        "Cohort 7a (VIR-2218 + VIR-3434)",
                        "Cohort 8a (VIR-2218 + VIR-3434)"
                    ],
                    "otherNames": [
                        "Elebsiran"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "VIR-3434",
                    "description": "VIR-3434 given by subcutaneous injection",
                    "armGroupLabels": [
                        "Cohort 1a (VIR-2218 + VIR-3434)",
                        "Cohort 1b (VIR-3434)",
                        "Cohort 1c (VIR-2218 + VIR-3434 + PEG-IFN\u03b1)",
                        "Cohort 1d (VIR-3434 + PEG-IFN\u03b1)",
                        "Cohort 2a (VIR-2218 + VIR-3434)",
                        "Cohort 2b (VIR-3434)",
                        "Cohort 2c (VIR-2218 + VIR-3434 + PEG-IFN\u03b1)",
                        "Cohort 3a (VIR-2218 + VIR-3434)",
                        "Cohort 4a (VIR-2218 + VIR-3434)",
                        "Cohort 5a (VIR-2218 + VIR-3434)",
                        "Cohort 6a (VIR-2218 + VIR-3434)",
                        "Cohort 7a (VIR-2218 + VIR-3434)",
                        "Cohort 8a (VIR-2218 + VIR-3434)"
                    ],
                    "otherNames": [
                        "Tobevibart"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "PEG-IFN\u03b1",
                    "description": "PEG-IFN\u03b1 given by subcutaneous injection",
                    "armGroupLabels": [
                        "Cohort 1c (VIR-2218 + VIR-3434 + PEG-IFN\u03b1)",
                        "Cohort 1d (VIR-3434 + PEG-IFN\u03b1)",
                        "Cohort 2c (VIR-2218 + VIR-3434 + PEG-IFN\u03b1)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Proportion of participants with treatment-emergent adverse events (TEAEs)",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "Proportion of participants with serious adverse events (SAEs)",
                    "timeFrame": "Up to 116 weeks"
                },
                {
                    "measure": "Proportion of participants with hepatitis B surface antigen (HBsAg) loss (defined as undetectable HBsAg) at end of treatment",
                    "timeFrame": "Up to 48 weeks"
                },
                {
                    "measure": "Proportion of participants with HBsAg loss (defined as undetectable HBsAg) at 24 weeks post-end of treatment",
                    "timeFrame": "Up to 72 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Absolute serum HBsAg and change from baseline across all timepoints in the study",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "Nadir and maximum reduction of serum HBsAg from baseline",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "Proportion of participants achieving sustained suppression of HBV DNA (< lower limit of quantification (LLOQ) for >= 24 weeks after discontinuation of all treatment, including NRTIs)",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "For hepatitis B e-antigen (HBeAg)-positive participants: Proportion of participants with HBeAg loss (undetectable HBeAg) and/or anti-HBe seroconversion at any timepoint",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "For HBeAg-positive participants: Time to HBeAg loss (undetectable HBeAg) and/or anti-HBe seroconversion",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "Cmax",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "Clast",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "Tmax",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "Tlast",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "AUCinf",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "AUClast",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "%AUCexp",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "t1/2",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "\u03bbz",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "Vz/F",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "CL/F",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "Number of participants with incidence and titers of anti-drug antibody (ADA) (if applicable) to VIR-3434",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "Proportion of participants meeting criteria for nucleotide reverse transcriptase inhibitors (NRTI) discontinuation",
                    "timeFrame": "Up to 60 weeks"
                },
                {
                    "measure": "Proportion of participants meeting criteria for NRTI retreatment",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "Proportion of participants achieving undetectable HBsAg and sustained suppression of HBV DNA [below the LLOQ, target not detected (TND)] >/= 24 weeks after discontinuation of all treatment, including NRTIs",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "Proportion of participants with serum HBsAg < 10 IU/mL at end of treatment",
                    "timeFrame": "Up to 48 weeks"
                },
                {
                    "measure": "Proportion of participants with serum HBsAg < 10 IU/mL at 24 weeks post-end of treatment",
                    "description": "48 weeks treatment + 24 weeks post-end of treatment",
                    "timeFrame": "Up to 72 weeks"
                },
                {
                    "measure": "Proportion of participants with anti-HBs seroconversion",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "Time to achieve nadir of serum HBsAg",
                    "timeFrame": "Up to 110 weeks"
                },
                {
                    "measure": "Time to achieve serum HBsAg loss",
                    "timeFrame": "Up to 110 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female ages 18 - \\<66 years\n* Chronic HBV infection for \\>/= 6 months\n* On NRTI therapy for \\>/= 2 months at the time of screening\n\nExclusion Criteria:\n\n* Any clinically significant chronic or acute medical condition that makes the participant unsuitable for participation\n* Significant fibrosis or cirrhosis\n* History or evidence of drug or alcohol abuse\n* History of chronic liver disease from any cause other than chronic HBV infection\n* History of hepatic decompensation\n* History of anaphylaxis\n* History of allergic reactions, hypersensitivity, or intolerance to monoclonal antibodies, antibody fragments, or any excipients of VIR-3434\n* History of immune complex disease\n* History of known contraindication to any interferon product",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Study Inquiry",
                    "role": "CONTACT",
                    "phone": "415-654-5281",
                    "email": "clinicaltrials@vir.bio"
                }
            ],
            "locations": [
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94143",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32803",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21218",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Hillsborough",
                    "state": "New Jersey",
                    "zip": "08844",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.4776,
                        "lon": -74.62682
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "zip": "2C4",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "zip": "3M1",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Vancouver",
                    "zip": "2C7",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 49.24966,
                        "lon": -123.11934
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Frankfurt",
                    "zip": "60590",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 50.11552,
                        "lon": 8.68417
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Hannover",
                    "zip": "30625",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 52.37052,
                        "lon": 9.73322
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Mannheim",
                    "zip": "68167",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 49.4891,
                        "lon": 8.46694
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "WITHDRAWN",
                    "city": "Ulm",
                    "zip": "89081",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 48.39841,
                        "lon": 9.99155
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Hong Kong",
                    "state": "Shatin",
                    "country": "Hong Kong",
                    "geoPoint": {
                        "lat": 22.27832,
                        "lon": 114.17469
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "COMPLETED",
                    "city": "Hong Kong",
                    "state": "Tai Po",
                    "country": "Hong Kong",
                    "geoPoint": {
                        "lat": 22.27832,
                        "lon": 114.17469
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Hong Kong",
                    "country": "Hong Kong",
                    "geoPoint": {
                        "lat": 22.27832,
                        "lon": 114.17469
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Busan",
                    "zip": "49421",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 35.10278,
                        "lon": 129.04028
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03080",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "05505",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Yangsan",
                    "zip": "50612",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 35.34199,
                        "lon": 129.03358
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "WITHDRAWN",
                    "city": "Batu Caves",
                    "zip": "68100",
                    "country": "Malaysia",
                    "geoPoint": {
                        "lat": 3.23333,
                        "lon": 101.66667
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "WITHDRAWN",
                    "city": "Kajang",
                    "zip": "43000",
                    "country": "Malaysia",
                    "geoPoint": {
                        "lat": 2.99424,
                        "lon": 101.78875
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Kuala Lumpur",
                    "zip": "59100",
                    "country": "Malaysia",
                    "geoPoint": {
                        "lat": 3.1412,
                        "lon": 101.68653
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Chisinau",
                    "zip": "MD 2025",
                    "country": "Moldova, Republic of",
                    "geoPoint": {
                        "lat": 47.00556,
                        "lon": 28.8575
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Auckland",
                    "zip": "1010",
                    "country": "New Zealand",
                    "geoPoint": {
                        "lat": -36.84853,
                        "lon": 174.76349
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Auckland",
                    "zip": "2025",
                    "country": "New Zealand",
                    "geoPoint": {
                        "lat": -36.84853,
                        "lon": 174.76349
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Hamilton",
                    "zip": "3204",
                    "country": "New Zealand",
                    "geoPoint": {
                        "lat": -37.78333,
                        "lon": 175.28333
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "COMPLETED",
                    "city": "Tauranga",
                    "zip": "3110",
                    "country": "New Zealand",
                    "geoPoint": {
                        "lat": -37.68611,
                        "lon": 176.16667
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "COMPLETED",
                    "city": "Wellington",
                    "zip": "6021",
                    "country": "New Zealand",
                    "geoPoint": {
                        "lat": -41.28664,
                        "lon": 174.77557
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Bucharest",
                    "zip": "021105",
                    "country": "Romania",
                    "geoPoint": {
                        "lat": 44.43225,
                        "lon": 26.10626
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Chiayi City",
                    "zip": "60041",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 23.47917,
                        "lon": 120.44889
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Kaohsiung City",
                    "zip": "80756",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 22.61626,
                        "lon": 120.31333
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Kaohsiung City",
                    "zip": "83301",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 22.61626,
                        "lon": 120.31333
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Taichung City",
                    "zip": "40705",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 24.1469,
                        "lon": 120.6839
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Taipei City",
                    "zip": "100",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Taoyuan City",
                    "zip": "33305",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 24.95233,
                        "lon": 121.20193
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "COMPLETED",
                    "city": "Kyiv",
                    "zip": "01135",
                    "country": "Ukraine",
                    "geoPoint": {
                        "lat": 50.45466,
                        "lon": 30.5238
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "zip": "B15 2TH",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 52.48142,
                        "lon": -1.89983
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "E11FR",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "SE5 9RS",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Investigative Site",
                    "status": "RECRUITING",
                    "city": "Manchester",
                    "zip": "M8 5RB",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 53.48095,
                        "lon": -2.23743
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006506",
                    "term": "Hepatitis A"
                },
                {
                    "id": "D000006509",
                    "term": "Hepatitis B"
                },
                {
                    "id": "D000019694",
                    "term": "Hepatitis B, Chronic"
                },
                {
                    "id": "D000014777",
                    "term": "Virus Diseases"
                },
                {
                    "id": "D000006566",
                    "term": "Herpesviridae Infections"
                },
                {
                    "id": "D000006505",
                    "term": "Hepatitis"
                },
                {
                    "id": "D000006521",
                    "term": "Hepatitis, Chronic"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000008107",
                    "term": "Liver Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000006525",
                    "term": "Hepatitis, Viral, Human"
                },
                {
                    "id": "D000004769",
                    "term": "Enterovirus Infections"
                },
                {
                    "id": "D000010850",
                    "term": "Picornaviridae Infections"
                },
                {
                    "id": "D000012327",
                    "term": "RNA Virus Infections"
                },
                {
                    "id": "D000086982",
                    "term": "Blood-Borne Infections"
                },
                {
                    "id": "D000003141",
                    "term": "Communicable Diseases"
                },
                {
                    "id": "D000018347",
                    "term": "Hepadnaviridae Infections"
                },
                {
                    "id": "D000004266",
                    "term": "DNA Virus Infections"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9592",
                    "name": "Hepatitis A",
                    "asFound": "Hepatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9595",
                    "name": "Hepatitis B",
                    "asFound": "Hepatitis B",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21609",
                    "name": "Hepatitis B, Chronic",
                    "asFound": "Hepatitis B, Chronic",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9591",
                    "name": "Hepatitis",
                    "asFound": "Hepatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "asFound": "Virus Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9607",
                    "name": "Hepatitis, Chronic",
                    "asFound": "Chronic Hepatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9643",
                    "name": "Herpesviridae Infections",
                    "asFound": "B Virus Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11107",
                    "name": "Liver Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9610",
                    "name": "Hepatitis, Viral, Human",
                    "relevance": "LOW"
                },
                {
                    "id": "M7930",
                    "name": "Enterovirus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M13745",
                    "name": "Picornaviridae Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M15149",
                    "name": "RNA Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M2593",
                    "name": "Blood-Borne Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M20487",
                    "name": "Hepadnaviridae Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M7442",
                    "name": "DNA Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "asFound": "Chronic",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2787",
                    "name": "Herpes Simiae (B Virus)",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M19243",
                    "name": "Interferon-alpha",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}